These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8325203

  • 1. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.
    Soneru IL, Agrawal L, Murphy JC, Lawrence AM, Abraira C.
    Diabetes Care; 1993 Jun; 16(6):896-901. PubMed ID: 8325203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K, Cunningham GR, Comstock JP.
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M.
    Ann Intern Med; 1999 Mar 02; 130(5):389-96. PubMed ID: 10068412
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA, Goodman AM.
    N Engl J Med; 1995 Aug 31; 333(9):541-9. PubMed ID: 7623902
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
    Herz M, Sun B, Milicevic Z, Erickson P, Fövènyi J, Grzywa M, Pelikanova T.
    Clin Ther; 2002 Jan 31; 24(1):73-86. PubMed ID: 11833837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
    Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, Merante D.
    Acta Diabetol; 1999 Jun 31; 36(1-2):61-5. PubMed ID: 10436254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE.
    Diabetes Care; 2000 Sep 31; 23(9):1236-41. PubMed ID: 10977012
    [Abstract] [Full Text] [Related]

  • 15. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K, O'Dorisio TM, Falko JM.
    Am J Med; 1984 Dec 31; 77(6):1002-9. PubMed ID: 6439036
    [Abstract] [Full Text] [Related]

  • 16. Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up.
    Clauson P, Karlander S, Steen L, Efendic S.
    Diabet Med; 1996 May 31; 13(5):471-7. PubMed ID: 8737030
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?
    Trischitta V, Italia S, Raimondo M, Guardabasso V, Licciardello C, Runello F, Mazzarino S, Sangiorgi L, Anello M, Vigneri R.
    J Endocrinol Invest; 1998 Dec 31; 21(11):744-7. PubMed ID: 9972673
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
    Dills DG, Schneider J.
    Horm Metab Res; 1996 Sep 31; 28(9):426-9. PubMed ID: 8911977
    [Abstract] [Full Text] [Related]

  • 19. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.
    Johnston PS, Lebovitz HE, Coniff RF, Simonson DC, Raskin P, Munera CL.
    J Clin Endocrinol Metab; 1998 May 31; 83(5):1515-22. PubMed ID: 9589648
    [Abstract] [Full Text] [Related]

  • 20. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H, Dressler A, Ziemen M, HOE 901/300s Study Group.
    Diabetes Care; 2000 Aug 31; 23(8):1130-6. PubMed ID: 10937510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.